Skip to content

Drug interactions

Dasatinib + Rifapentine

Severity: Major

Dasatinib and Rifapentine: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rifapentine is a CYP3A4 inducer and is expected to reduce dasatinib exposure considerably. This may result in subtherapeutic levels and treatment failure.

What this interaction means in plain words

Dasatinib and Rifapentine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Dasatinib belongs to Oncology; Rifapentine belongs to Anti Bacterial.

Evidence level: Moderate

Why it happens

Induction of CYP3A4 increases the metabolic clearance of dasatinib.

What to do

Avoid the combination if possible, since the rifamycin effect on dasatinib is substantial. If unavoidable, consider a higher dasatinib dose with close monitoring of response and toxicity.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dasatinib and Rifapentine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dasatinib with Rifapentine?

MediHelp rates the interaction as major. Dasatinib and Rifapentine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Rifapentine is a CYP3A4 inducer and is expected to reduce dasatinib exposure considerably. This may result in subtherapeutic levels and treatment failure.

How serious is the interaction between Dasatinib and Rifapentine?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible, since the rifamycin effect on dasatinib is substantial. If unavoidable, consider a higher dasatinib dose with close monitoring of response and toxicity.

What other medicines interact with Dasatinib?

MediHelp also lists interactions of Dasatinib with, for example, Saquinavir, Thioridazine, Adagrasib. The full list is on the Dasatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in